Association of Major Modifiable Risk Factors Among Patients with Coronary Artery Disease - A Retrospective Analysis

Size: px
Start display at page:

Download "Association of Major Modifiable Risk Factors Among Patients with Coronary Artery Disease - A Retrospective Analysis"

Transcription

1 Original Article Association of Major Modifiable Risk Factors Among Patients with Coronary Artery Disease - A Retrospective Analysis V Achari, AK Thakur Abstract Background : The relative importance of various risk factors varies in different regions of India. This was a retrospective study of patients with recently diagnosed coronary artery disease to assess four major risk factors: dyslipidemia, hypertension, smoking and diabetes. Material and Methods : A total of 5748 patients (4952 males, 796 females) with recently diagnosed coronary artery disease were analysed from the records of Heart Hospital along with 8103 controls (6092 males and 2011 females). Absolute lipid levels as well as prevalence of dyslipidemia using the ATP III guidelines were assessed. They were classified into two major groups premature CAD (males < 45 years females < 55 years) and CAD at usual age (males 45 years, females 55 years). Results : The most common pattern of CAD was chronic stable angina (n=2773, 48.24%). Mean total cholesterol (TC), LDL cholesterol and TC/HDL ratio were significantly higher in subjects with CAD compared to subjects without CAD controls. The mean HDL cholesterol and triglyceride levels were similar in both groups. Elevated LDL cholesterol, decreased HDL cholesterol, elevated total cholesterol and abnormal TC/HDL ratios were more common in CAD patients as compared to controls (38.8% vs %, 29.3% vs 18.2%, 36.9% vs 32.5% and 59.05% vs 44.3% respectively). However lipid abnormalities were not significantly different in females 55 in CAD vs non-cad group. Smoking was significantly more common in subjects with CAD groups (30.97% vs %) as compared to subjects without CAD (P < ). It was most common in males with premature CAD (44.1% P < ). Hypertension was found in 1036 patients (18.02%) and diabetes in 763 (13.28%) as compared to 1126 (13.9%) hypertensives in non-cad group and 639 diabetics (7.89%) (P = 0.001), both were more common in males 45 and females 55 as compared to those with premature CAD (p < 0.01). Conclusion : Among the risk factors assessed, dyslipidemia (particularly abnormal TC/HDL ratio and elevated LDL cholesterol), smoking hypertension and diabetes were associated with coronary artery disease in decreasing order of prevalence. In premature CAD, dyslipidemia and (in males) smoking are of particular importance. INTRODUCTION With the explosive rise in the incidence of coronary artery disease (CAD), it is now estimated that this will be the leading cause of mortality and morbidity even in the developing world by the year Over 200 risk factors for CAD have been identified or postulated, of which dyslipidemia, hypertension and smoking appear to be the most important. 2 A major component of this epidemic is due to treatable factors, which if controlled will go a long way in Heart Hospital, Kankarbagh, Patna. Received : ; Accepted : stemming the epidemic. These risk factors have been classified ranging from class II (intervention likely to lower cardiovascular risk), class III (factors if modified might lower cardiovascular risk) and class IV (unmodifiable risk factors). 3 Dyslipidemia is classified partly as a class I risk factor (LDL cholesterol) and class II (triglycerides). Hypertension and smoking are regarded as class I risk factor while diabetes considered a class II risk factor. While there have been some studies on lipids and other factors in Delhi 4 and Vellore 5 and other cities there is a paucity of data on prevalence of such factors in many states including Bihar and this study is an effort to provide some information JAPI VOL. 52 FEBRUARY

2 on this subject. MATERIAL AND METHODS This was a retrospective study conducted between from the records of Heart Hospital, Kankarbagh, Patna. Patients were diagnosed as having CAD on the basis of at least one of the following criteria: 1. History of documented angina/infarction. 2. ECG findings namely Minnesota codes 1-1, 4-1, 5-1, 5-2 or 9-2 highly suggestive of silent MI A positive treadmill test or stress echocardiographyhighly suggestive of silent MI 4. History of angina/mi in past with ECG confirmation. 5. Angiographic evidence of CAD or history of PTCA/ CABG Five thousand seven hundred and forty-eight patients with complete data and newly diagnosed CAD were selected for study. The major risk factors that were assessed in the study included dyslipidemia, smoking, hypertension and diabetes mellitus. Criteria for dyslipidemia were those recommended by the National Cholesterol Education Programme (ATP III) guidelines. 7 All individual with a history of smoking (either present or within the past year) were classified as smokers. This included Bidi smokers and tobacco chewers. Hypertension was diagnosed and classified according to the JNC VI criteria. 8 A fasting plasma glucose 126 mg/dl or previous history of diabetes mellitus was required for the diagnosis of diabetes. 9 For lipid profile estimation blood samples were taken after on overnight fast. Patients with acute MI/acute coronary syndromes or cardiac surgery had lipid estimation two months after the event. Eight thousand one hundred and three individuals who attended the hospital for routine checkup or non-specific cardiovascular symptoms but in whom CAD was ruled out with appropriate investigations (ECG, echocardiography and treadmill testing) were taken as control. The lipid levels of the two groups as well as smoking habits were compared. Some of these individuals were the lipid profile (e.g. hypothyroidism, alcoholism, chronic liver disease, chronic renal failure, drug therapy) were excluded from the study. The number of patients with alcoholism/chronic liver disease (CAD) and on statin therapy (at the level of initial assessment) were 351 and 217 respectively among the subset with CAD; and 408 and 131 among subjects without CAD. These individuals were not included in the study. Statistical Analysis Numerical variables were reported as mean ± SD. The chi square test was used for categorical variables and t-test for continuous variables. A P value of < 0.01 was considered significant in view of the large sample size. The data were analysed using Minitab statistical software. RESULTS Five thousand seven hundred and forty-eight patients (4952 males, 796 females) were in the CAD group while among the 8103 subjects without CAD there were 6092 males and 2011 females) all the subjects with and without CAD were in the age group 30-80, the maximum number were in the age group (Table 1). The patients with CAD were classified as premature CAD (men < 45, women < 45) and CAD at usual age (mean 45, women 55). The prevalence of premature CAD was much higher in women as compared to men (82.2% as compared to 32.5% respectively) (p < 0.001). Among subjects < 45 almost equal number of males were studied in both the groups (with CAD, n = 1608; without CAD, n=1657). Table 1 : Age and sex distribution of subjects examined in CAD and non-cad group (n=5748) (n=8103) Males < * 1657 (Premature CAD) (27.97%) (20.44%) Males (58.17%) 4435 (54.73%) Females < * 1546 (Premature CAD) (11.38%) (19.08%) Females (2.47%) 465 (5.74%) *p<0.001 Subgroup analysis of the females subjects with and without CAD in three age groups - < 45, and 55 years indicated that there was a steep rise in the prevalence of CAD among females in the age group as compared to females < 45 years - (68.71% vs 13.44%, p = < 0.001) (Table 1a). Table 1a : Age distribution of females with and without CAD (n=796) (n=2011) Females 107 (13.44%)* 582 (28.91%)* < 45 years Females 547 (68.71%)* 964 (47.93%) < years Females 55 years 142 (17.85%) 465 (23.16%) *p = < Among the patterns of CAD found in the study population, the most common was chronic stable angina (2773 out of 5748, 48.24%). The next common group was those with positive treadmill test/stress echocardiography (30.4%) (17.9%) had documented myocardial infarction with ECG changes (Minnesota codes). A much smaller number had angiographically proved CAD / history of PTCA / CABG or acute coronary syndromes. When the mean lipid levels were compared in the two groups it was observed that the mean total cholestrol, LDL cholesterol, TC:HDL-C ratio and mean LDL-C: HDL-C ratio were significantly higher in the subjects with CAD (p < 0.01 for all the lipid parameters). The difference in the mean VLDL, HDL cholesterol and triglycerides in both the groups was not significant (Table 2). It is apparent from a perusal of age and sex distribution of the lipid levels that the mean total cholesterol (TC), LDL JAPI VOL. 52 FEBRUARY 2004

3 choleserol (LDL-c) and total cholesterol/hdl (TC/HDL) were significantly higher in male subjects less than 45 years and more than 45 years. No significant difference was noted in the mean lipid parameters studied of the females > 55 years in the group with and without CAD. The most common type of dyslipidemia with was an elevated TC/HDL ratio > 4.5; it was found in 59.05% of patients and 44.3% of subjects without CAD (p < 0.01). The prevalence of elevated total cholesterol ( 200 mg/dl), low HDL cholesterol 40 mg/dl and LDL choleserol 130 mg/dl also markedly higher in patients as compared to non-cad group; these values were strongly significant (p=<0.01). On the contrary, hypertriglyceridemia did not seem to be an important association of CAD; nearly equal number of subjects in both groups had elevated triglycerides 150 gm/ dl (Table 4). The prevalence of smoking was 1780 (30.97%) in the patients group as compared to 1031 (12.72%) in non-cad group, this was strongly significant (p = < ). This was Table 2 : Patterns of CAD in the study population Symptoms and ECG findings No. of cases (% of cases) Chronic stable angina with ST-T changes in ECG 2773 (48.2%) Positive treadmill test/stress echocardiography 1745 (30.4%) Documented myocardial infarction with ECG 1027 (17.9%) changes (Minnesota codes) Angiographically proved CAD/history of PTCA/CABG 105 (1.8%) Acute coronary syndromes 98 (1.7%) Total 5748 (100%) Table 4 : Mean lipid levels (age and sex distribution) also true of tobacco chewers (p = < 0.001). Males had a higher prevalence of smoking in both age groups (CAD and non- CAD) (Table 5) as compared to females; this was particularly true of males with premature CAD (< 45). Seven hundred and fifty-two males below 45 with CAD (44.1%) had history of smoking or tobacco chewing as compared to 775 males 45 years (19.96%, p = < 0.001). Hypertension and diabetes were comparatively less common than lipid abnormalities and smoking respectively (Table 6). Both risk factors were uncommon in individuals <45 years but comparatively more common in middle-aged and elderly CAD. Hypertension was noted more often in subjects with CAD as compared to those without CAD (18.02% vs. 13.9%, p < 0.005) and similar data were true of Table 3 : Mean lipid levels in subjects with and without CAD Subjects with Subjects P CAD without CAD (n=5748) (n=8103) Mean total ± ± < 0.01 Mean LDL ± ± 37.9 < 0.01 Mean HDL ± ± NS Mean VLDL ± ± NS Mean TC/HDL ratio 4.62 ± ± 0.29 < 0.01 Mean LDL/HDL ratio 3.09 ± ± 0.29 < 0.01 TC/HDL - Total cholesterol / HDL cholesterol ratio; NS - not significant Males < 45 TC (mg/dl) * Males < 45 TC (mg/dl) * (n=1608) LDL-C ** (n=1657) LDL-C ** HDL-C HDL-C VLDL-C VLDL-C TG TG TC/HDL ratio ** TC/HDL radio ** Males 45 TC (mg/dl) Males 45 TC (mg/dl) * (n=3344) LDL-C ** (n=4435) ldl-c ** HDL-C HDL-C VLDL-C VLDL-C TG TG TC/HDL ratio ** TC/HDL ratio ** Females < 55 TC (mg/dl) * Females < 55 TC (mg/dl) (n=654) LDL-C ** (N=1546) LDL-C ** HDL-C HDL-C VLDL-C VLDL-C TG TG TC/HDL radio ** TC/HDL ratio Females 55 TC (mg/dl) Females 55 TC (mgdl) (n=142) LDL-C (n=465) LDL-C HDL-C HDL-C VLDL-C VLDL-C TG TG TC/HDL ratio TC/HDL ratio *p < 0.05 (cases vs controls); **p < (cases vs controls) JAPI VOL. 52 FEBRUARY

4 Table 5 : Prevalence of dyslipidemia (ATP III criteria) and abnormal TC/HDL ratio (N=5748) (N=8103) Males Females Total Males Females Total (n=4952) (n=746) (n=6092) (n=2011) TC 200 md/dl ** (37.6%) (34.71%) (36.9%) (33.3%) (30.29%) (32.5%) LDL-C 130 mg/dl * (37.52%) (35.12%) (36.8%) (33.4%) (32.37%) (33.14%) HDL-C<40 mg/dl * (30.4%) (23.86%) (29.3%) (18.9%) (16.17%) (18.2%) Triglycerides 150 mg/dl (45.05%) (39.94%) (45.74%) (46.41%) (48.09%) (46.84%) TC/HDL ratio > * (60.3%) (54.7%) (59.05%) (47%) (36.46%) (44.3%) *p = < 0.001; **p = < 0.01 Table 6 : Prevalence of smoking and CAD (n = 5748) (n=8103) Smokers Tobacco Total Smokers Tobacco Total chewers chewers Males < 45 (premature CAD) * * (n=1608)+ (38.2%) (8.9%) (8.9%) (19.59%) (3.31%) (22.9%) Males 45 (n=3344) (16.02%) (3.94%) (19.96%) (10.05%) (2.1%) (12.15%) Females < 55 (premature ** ** CAD) (n=654) (14.3%) (2.14%) (15.44%) (4.27%) (1.1%) (5.37%) Females ** ** (12.68%) (4.22%) (16.9%) (5.14%) (0.86%) (6%) Total *p=<0.001 (male subjects with CAD vs males without CAD, male CAD < 45 vs CAD 45); **p=0.003 (females patient vs female control); +p=<0.001 (males vs females with CAD) Table 7 : Prevalence of hypertension and diabetes mellitus N Hypertension Type II diabetes N Hypertension Type II diabetes Mellitus Mellitus Males < 45 years (Premature * * 58 CAD) (11.2%) (5.5%) (4.65%) (3.5%) Males 45 years ** 549* * 409* (21.2%) (16.4%) (16.23%) (9.2%) Females < 55 years * (15.4%) (15.3%) (15.71%) (8%) Females 55 years * 27* (19%) * 48* (32.4%) (18.9%) (10.3%) Subject with CAD vs *p = < 0.01 subjects without CAD +p = < 0.01 (premature CAD vs CAD in middle age) diabetes (13.28% vs. 7.89%, p < 0.001). There was no significant sex difference in the prevalence of hypertension or diabetes in either patients or non-cad subjects. DISCUSSION A number of risk factors have been identified in CAD, 3 of the factors analysed in this study smoking and hypertension are class I risk factors. Elevated LDL cholesterol is also a class I risk factors. Hypertriglycerdemia and diabetes mellitus are known as class II risk factors. The most obvious findings was the very high prevalence of premature CAD in women (82.2% of all women with CAD) as compared to only 32.5% of men with premature CAD. This can be partly explained by early menopause in Indian women which to a great extent reduces the protective effect of estrogens. 3 Although, the age of menopause was not recorded in most of the data, the abrupt rise in the prevalence of CAD among women between years of age as compared to younger women indicates that this is likely. In this large retrospective study of subjects with and without CAD, dyslipidemia, as manifested by an abnormal TC/HDL ratio (present in 59.5% of CAD patients) was the JAPI VOL. 52 FEBRUARY 2004

5 most common form of lipid abnormality as well as the most common of the risk factors analysed. There was no significant difference in the prevalence of hypertriglyceridemia in CAD cases as compared to non-cad individuals. In terms of absolute mean values, only total cholesterol, LDL cholesterol, TC/HDL and LDL/HDL choleserol ratios were significantly higher in CAD group. On analyzing the four groups (males < 45 with CAD; males 45 with CAD; females < 55 with CAD; females 55 with CAD as compared to corresponding non- CAD individuals of these age groups), mean total cholesterol, LDL cholesterol, TC/HDL ratios were higher in both groups of males and also in females below 55; however females 55 with CAD did not show any significant difference in their mean lipid levels or TC/HDL ratio as compared to non-cad females. Most international studies e.g. the MRFIT Study Group; 10 Seven Countries Study 11 and Framingham Study 12,13 emphasized the importance of elevated LDL and TC in the development of CAD. They also considered these factors as more important than the other risk factors studied (hypertension, smoking and diabetes). Several studies have been performed in different regions of India and have revealed considerable varying results with respect to prevalence and type of dyslipidemia. Most studies have observed elevated total and LDL cholesterol levels as well as triglycerides A recent study of Gupta et al1 4 indicated that elevated TC and LDL cholesterol, low HDL cholesterol and trglycerides was associated with CAD. On the contrary, a study by Pais et al 17 in survivors of acute myocardial infarction (AMI) showed no association of lipid abnormalities with CAD. In this study smoking showed the strongest association with CAD. Gopinath et al 18 who studied lipid profiles of subjects with and without CAD found that three major fractions of lipid profiles (TC, triglycerides and LDL cholesterol) were higher in both rural and urban population with CAD as compared to control while HDL cholesterol was lower. A recent population based study by Mohan et al in Chennai 19 showed that after multivariate analysis, only elevated LDL choleserol was associated with the presence of CAD. A recent study by Anand et al 20 (in Canada) among three ethnic groups showed that South Asians had the highest prevalence of CAD. Mean TC, LDL-C and triglycerides were significantly higher in South Asians while LDL-C was lower. Smoking was less common in this ethnic group while diabetes was significantly more common and compared to Europeans or Chinese. Our study indicates the major abnormalities in mean lipid levels as well as prevalence of dyslipidemia was (in order of prevalence) elevated TC/HDL ratio, elevated TC and LDL-C levels and low HDL-C, the last abnormality was more common in CAD group but mean HDL levels were not significantly different. Triglycerides did not seem to be significant either in absolute mean levels or relative prevalence of hypertriglyceridemia. The present study is in agreement with other studies on dyslipidemias with one significant difference in that triglycerides (either in terms of absolute level or in the prevalence of hypertriglyceridemia) did not seem to be an important risk factor. Smoking was the second most important factor and was significantly more common in males than females. Only 12.72% of the control population smoked as compared to nearly 31% in the CAD group. Smoking as well as tobacco chewing were significantly more common in all groups of CAD as compared to subjects without CAD, but it is most common in males with premature CAD (< 45). This is in agreement with the study of Pais 17 while Gupta et al 14 found a low prevalence of smoking in both cases and controls. Hypertension and diabetes were more closely associated than in the general population this is in keeping with the metabolic syndrome which is often seen in type 2 diabetics. Both these risk factors were markedly more common in CAD. However they had a much lower prevalence than lipid abnormalities or smoking. With the exception of premature CAD in females (< 55), hypertension and smoking were more common in subjects with CAD as compared to subjects without CAD. Premature CAD individuals had a comparatively lower prevalence of hypertension and diabetes mellitus. These results therefore indicate that dyslipidemia (abnormal TC/HDL ratios, elevated LDL cholesterol and total cholesterol), smoking, hypertension and diabetes mellitus, in that order of prevalence were the major risk factors or associations of CAD. Of theses dyslipidemia, hypertension and smoking are definitely treatable while diabetes mellitus is possibly treatable. This is in agreement with many other international studies e.g. MRFIT which have identified elevated cholesterol levels as the most important risk factor for CAD. Our study has the following limitations 1. Being a retrospective analysis it merely identified associations of coronary artery disease rather than risk factors in the real sense-the latter would require a long term follow-up of a population cohort. 2. As the data were collected over a relatively long period of time, it was not possible to analyse the change in relative importance of risk factors with changing population habits and lifestyles. It may therefore be concluded that a comprehensive multicentric Indian study of all regions of the country is required to provide a better picture of the risk factor profile for CAD in Indian subjects. In the mean time, emphasis should be on diagnosis and control of dyslipidemia, type 2 diabetes, hypertension and cessation of smoking which have been identified in this large study as major risk factors for coronary artery disease. REFERENCES 1. Reddy KS. Cardiovascular disease in India. Would Health Stat Q 1993;46: Castelli WP. Lipids risk factors and ischemic heart disease. JAPI VOL. 52 FEBRUARY

6 Atherosclerosis 1996;124:S1-S9. 3. Fuster V, Pearson TA. 27th Betheseda Conference. Matching the intensity of risk factor management with the hazard of coronary heart disease events. J Am Coll Cardiol 1996;27: Vashisht S, Narula J, Awtade A, Tandon R, Srivastava IM. Lipid and lipoproteins in normal controls and clinically documented coronary heart disease patients. Ann Nat Acad Med Sc 1990;26: Krishnaswamy S. Conventional risk factors for coronary heart disease in Indian patients: In Sethi KK (ed) Coronary Artery Disease in Indians: A global perspective New Delhi Cardiological Society of India 1998: Blackburn H, Prineaqs RJ, Crow PS. The Minnesota Code: Electrocardiographic Findings - Standards and Procedures for Measurement and Classifications: Littleton Mass Wright. 7. Executive Summary of the Third Report of the National Cholesterol Educatin Programme (NCEP) Expert Paneal on Detection. Elevation and treatment of high bliood cholesterol in adults (Adults treatment panel III). JAMA 2001;285: The sixth report of the national committee on prevention, detection, evaluation and treatment of high blood pressure (JNC VI). Arch Internal Med 1997;157: Report of The Expert Committee n the Diagnosis and Classification of Diabetes Mellitus. The Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes care 2001;24:S1-S Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking and death from coronary heart disease : Overall findings and differences by age for 316, 099 white men. Multiple risk factor intervention trial Research Group. Arch Int Med 1992: Keys A, Menotti A, Karvonen MJT AL. The Diet and 15 year death rate in the seven countries study. Am J Epidemiology 1986;124: Levy D, Kannel WB. Cardiovascular risks. New insights from framingham. Am Heart J 1988;116: Castelli WP. Epidemiology of caronary heart disease. The Framingham Study. Am J Med 1984;76(Supll.2A): Gupta R, Vashisht S, Bahl VK, Wasir HS, Correlation of lipoprotein (A) to angiograpically defined coronary artery disease in Indians. Int J Cardiol 1996;57: Sahi N, Pahlajani DB, Sainani GS. Apolipoprotein A1 and B as predictors of angiographically associated coronary artery disease. J Assoc Phy India 1993;41: Gupta R, Kaul V, Prakash H, Sarna M. Singhal Shalini, Gupta VP. Lipid abnormalities in coronary heart disease. A population based case control study. Indian Heart J 2001;53: Pais P, Pogue S, Gerstein H, Zachariah E, Savitha D, Jayprakash S, et al. Risk factors for acute myocardial infarction: A case control study. Lancet 1996;348: Gopinath N, Chadha SL, Sehghal A, Shekhawat S, Tandon R. What is a Desirable lipid profile. Ind Heart J 1994;46: Mohan V, Deepa R, Rani SS, Premalatha G. Prevalence of coronary artery disease and its relationship with lipids in a selected population in South India : The Chennai urban population study (CUPS No.5). J Am Coll Cardiol 2001;38: Anand Sonia S, Ysusf Salim Vuksan Vladimir, Devanesan Sudarshan, Teo Koon K, Montague Partricia A, et al. Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: The study of health assessment and risk in ethnic groups (SHARE). Lancet 2000;356: Announcement XXII Conference of Association of Physicians of India. Karnataka Chapter - KAPICON th, 15th and 16th May, 2004, Kuvempu Ranga Mandir, Shimoga, Karnataka For further details, please contact : Dr. PK Pai / Dr. KR Ravish, Organizing Secretaries, Conference Secretariat Sahyadri Hospital, OT Road, Shimoga Tel: , ; Fax: JAPI VOL. 52 FEBRUARY 2004

Study of cardiovascular risk factor profile among first-degree relatives of patients with premature coronary artery disease at Kota, Rajasthan, India

Study of cardiovascular risk factor profile among first-degree relatives of patients with premature coronary artery disease at Kota, Rajasthan, India International Journal of Community Medicine and Public Health Mittal D et al. Int J Community Med Public Health. 2016 Jul;3(7):1894-1899 http://www.ijcmph.com pissn 2394-6032 eissn 2394-6040 Research Article

More information

Indian Journal of Basic & Applied Medical Research; December 2011: Issue-1, Vol.-1, P

Indian Journal of Basic & Applied Medical Research; December 2011: Issue-1, Vol.-1, P Comprehensive levels of Serum Enzymes and Lipid Profile testing in MI and Stable Angina Subjects. K.Satya Narayana*, Dr.Anija Uchuru**, Dr.Ivvala Anand Shaker*, S.Saleem Basha*, K.Suresh Babu* *Dept of

More information

Prevalence of Cardiovascular Risk Factors in Indian Patients Undergoing Coronary Artery Bypass Surgery

Prevalence of Cardiovascular Risk Factors in Indian Patients Undergoing Coronary Artery Bypass Surgery Original Article Prevalence of Cardiovascular Risk Factors in Indian Patients Undergoing Coronary Artery Bypass Surgery RR Kasliwal*, A Kulshreshtha**, Sweta Agrawal**, M Bansal***, N Trehan+ Abstract

More information

The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India

The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India eissn: 09748369, www.biolmedonline.com The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India M Estari, AS Reddy, T Bikshapathi,

More information

How would you manage Ms. Gold

How would you manage Ms. Gold How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56

More information

HDL-C. J Jpn Coll Angiol, 2008, 48: NIPPON DATA80, MEGA study, JELIS, dyslipidemia, risk assessment chart

HDL-C. J Jpn Coll Angiol, 2008, 48: NIPPON DATA80, MEGA study, JELIS, dyslipidemia, risk assessment chart Online publication March 25, 2009 48 6 2007 2007 HDL-C LDL-C HDL-C J Jpn Coll Angiol, 2008, 48: 463 470 NIPPON DATA80, MEGA study, JELIS, dyslipidemia, risk assessment chart 1987 NIPPON DATA80 Iso 10 MRFIT

More information

Study of fixed dose combination for the management of cardiovascular diseases

Study of fixed dose combination for the management of cardiovascular diseases World Journal of Pharmaceutical Sciences ISSN (Print): 2321-331; ISSN (Online): 2321-386 Available online at: http://www.wjpsonline.org/ Original Article Study of fixed dose combination for the management

More information

Statistical Fact Sheet Populations

Statistical Fact Sheet Populations Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total

More information

Plasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension

Plasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original

More information

DECLARATION OF CONFLICT OF INTEREST. None

DECLARATION OF CONFLICT OF INTEREST. None DECLARATION OF CONFLICT OF INTEREST None BURDEN OF CORONARY ARTERY DISEASE IN DIABETES IN INDIA Amal Kumar Banerjee MD, DM,FACC,FESC,FACP,FAPSC,FICC President Association of Physicians of India SAARC Cardiac

More information

Prediction of Cardiovascular Disease in suburban population of 3 municipalities in Nepal

Prediction of Cardiovascular Disease in suburban population of 3 municipalities in Nepal Prediction of Cardiovascular Disease in suburban population of 3 municipalities in Nepal Koju R, Gurung R, Pant P, Humagain S, Yogol CM, Koju A, Manandhar K, Karmacharya B, Bedi TRS Address for Correspondence:

More information

Review of guidelines for management of dyslipidemia in diabetic patients

Review of guidelines for management of dyslipidemia in diabetic patients 2012 international Conference on Diabetes and metabolism (ICDM) Review of guidelines for management of dyslipidemia in diabetic patients Nan Hee Kim, MD, PhD Department of Internal Medicine, Korea University

More information

The Metabolic Syndrome Its Prevalence and Association with Coronary Artery Disease in Type 2 Diabetes

The Metabolic Syndrome Its Prevalence and Association with Coronary Artery Disease in Type 2 Diabetes REVIEW ARTICLE JIACM 2006; 7(1): 32-8 Abstract The Metabolic Syndrome Its Prevalence and Association with Coronary Artery Disease in Type 2 Diabetes Vijay Achari*, AK Thakur**, Arun K Sinha*** Objective:

More information

The Best Lipid Fraction for the Prediction of the Population at Risk of Atherothrombotic Disease. William E. Feeman, Jr., M.D.

The Best Lipid Fraction for the Prediction of the Population at Risk of Atherothrombotic Disease. William E. Feeman, Jr., M.D. The Best Lipid Fraction for the Prediction of the Population at Risk of Atherothrombotic Disease William E. Feeman, Jr., M.D. 640 South Wintergarden Road Bowling Green, Ohio 43402 Phone 419-352-4665 Fax

More information

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION 2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL

More information

Title for Paragraph Format Slide

Title for Paragraph Format Slide Title for Paragraph Format Slide Presentation Title: Month Date, Year Atherosclerosis A Spectrum of Disease: February 12, 2015 Richard Cameron Padgett, MD Executive Medical Director, OHVI Pt RB Age 38

More information

It is currently estimated that diabetes prevalence by

It is currently estimated that diabetes prevalence by clinical Study The Prevalence and Pattern of Dyslipidemia among Type 2 Diabetic Patients at Rural Based Hospital in Gujarat, India Hetal Pandya*, JD Lakhani**, J Dadhania, A Trivedi Abstract Only proper

More information

CARDIOVASCULAR DISEASE RISK FACTOR ESTIMATION IN GUJARATI ASIAN INDIAN POPULATION USING FRAMINGHAM RISK EQUATION

CARDIOVASCULAR DISEASE RISK FACTOR ESTIMATION IN GUJARATI ASIAN INDIAN POPULATION USING FRAMINGHAM RISK EQUATION ORIGINAL ARTICLE CARDIOVASCULAR DISEASE RISK FACTOR ESTIMATION IN GUJARATI ASIAN INDIAN POPULATION USING FRAMINGHAM RISK EQUATION Sibasis Sahoo 1, Komal Shah 2,Anand Shukla 3, Jayesh Prajapati 3, Pratik

More information

1. Which one of the following patients does not need to be screened for hyperlipidemia:

1. Which one of the following patients does not need to be screened for hyperlipidemia: Questions: 1. Which one of the following patients does not need to be screened for hyperlipidemia: a) Diabetes mellitus b) Hypertension c) Family history of premature coronary disease (first degree relatives:

More information

Comparison of Original and Generic Atorvastatin for the Treatment of Moderate Dyslipidemic Patients

Comparison of Original and Generic Atorvastatin for the Treatment of Moderate Dyslipidemic Patients Comparison of Original and Generic Atorvastatin for the Treatment of Moderate Dyslipidemic Patients Cardiology Department, Bangkok Metropolitan Medical College and Vajira Hospital, Bangkok, Thailand Abstract

More information

Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women

Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women European Heart Journal (2002) 23, 528 535 doi:10.1053/euhj.2001.2888, available online at http://www.idealibrary.com on Combined effects of systolic blood pressure and serum cholesterol on cardiovascular

More information

4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for

4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for + Update on Lipid Management Stacey Gardiner, MD Assistant Professor Division of Cardiovascular Medicine Medical College of Wisconsin + The stats on heart disease Over the past 10 years for which statistics

More information

Frequency of Dyslipidemia and IHD in IGT Patients

Frequency of Dyslipidemia and IHD in IGT Patients Frequency of Dyslipidemia and IHD in IGT Patients *Islam MS, 1 Hossain MZ, 2 Talukder SK, 3 Elahi MM, 4 Mondal RN 5 Impaired glucose tolerance (IGT) is often associated with macrovascular complications.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Leibowitz M, Karpati T, Cohen-Stavi CJ, et al. Association between achieved low-density lipoprotein levels and major adverse cardiac events in patients with stable ischemic

More information

Research Article. Deepika Mittal 1, Shivraj Meena 2 *, Rahul Meena 1, Kirti Shekhawat 3

Research Article. Deepika Mittal 1, Shivraj Meena 2 *, Rahul Meena 1, Kirti Shekhawat 3 International Journal of Research in Medical Sciences Mittal D et al. Int J Res Med Sci. 2016 Aug;4(8):3354-3359 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20162293

More information

POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) Term-End Examination June, 2015

POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) Term-End Examination June, 2015 No. of Printed Pages : 20 MCC-006 POST GRADUATE DIPLOMA IN CLINICAL 0 CARDIOLOGY (PGDCC) Term-End Examination June, 2015 MCC-006 : CARDIO VASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note :

More information

Clinical Study of Lipid Profile Pattern in Acute Coronary Syndromes

Clinical Study of Lipid Profile Pattern in Acute Coronary Syndromes Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2017/359 Clinical Study of Lipid Profile Pattern in Acute Coronary Syndromes V Suresh Kumar, Madavaram Sreelatha Assistant

More information

Preventing Myocardial Infarction in the Young Adult in the First Place: How Do the National Cholesterol Education Panel III Guidelines Perform?

Preventing Myocardial Infarction in the Young Adult in the First Place: How Do the National Cholesterol Education Panel III Guidelines Perform? Journal of the American College of Cardiology Vol. 41, No. 9, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00187-6

More information

Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines

Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines Paul Mahoney, MD Sentara Cardiology Specialists Lipid Management in Cardiovascular Disease

More information

Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL

Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL Sung-Joon Lee, PhD Division of Food Science Institute of Biomedical Science and Safety Korea University Composition of Lipoproteins:

More information

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein

More information

Predisposing Factors to Premature Coronary Artery Disease in Young (Age 45 Years) Smokers: A Single Center Retrospective Case Control Study from India

Predisposing Factors to Premature Coronary Artery Disease in Young (Age 45 Years) Smokers: A Single Center Retrospective Case Control Study from India J Cardiovasc Thorac Res, 2014, 6(1), 15-19 doi: 10.5681/jcvtr.2014.003 http://journals.tbzmed.ac.ir/jcvtr TUOMS Publishing Group Research Article Predisposing Factors to Premature Coronary Artery Disease

More information

Case Study: Chris Arden. Peripheral Arterial Disease

Case Study: Chris Arden. Peripheral Arterial Disease Case Study: Chris Arden Peripheral Arterial Disease Patient Presentation Diane is a 65-year-old retired school teacher She complains of left calf pain when walking 50 metres; the pain goes away after she

More information

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003 Authorized By: Medical Management Guideline Committee Approval Date: 12/13/01 Revision Date: 12/11/03 Beta-Blockers Nitrates Calcium Channel Blockers MEDICATIONS Indicated in post-mi, unstable angina,

More information

Evaluation of hs-crp levels in acute coronary syndromes

Evaluation of hs-crp levels in acute coronary syndromes Original Research Article Evaluation of hs-crp levels in acute coronary syndromes R. S. Pushpa Kumari 1*, Priya John 2, V. A. Vipula 3 1 Professor, Department of General Medicine, MNR Medical College and

More information

THE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES

THE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES Int. J. LifeSc. Bt & Pharm. Res. 2013 Varikasuvu Seshadri Reddy et al., 2013 Review Article ISSN 2250-3137 www.ijlbpr.com Vol. 2, No. 1, January 2013 2013 IJLBPR. All Rights Reserved THE EFFECT OF VITAMIN-C

More information

GUIDELINES FOR DYSLIPIDEMIA MANAGEMENT AND EDUCATION THROUGH NOVA SCOTIA DIABETES CENTRES

GUIDELINES FOR DYSLIPIDEMIA MANAGEMENT AND EDUCATION THROUGH NOVA SCOTIA DIABETES CENTRES GUIDELINES FOR DYSLIPIDEMIA MANAGEMENT AND EDUCATION THROUGH NOVA SCOTIA DIABETES CENTRES Prepared by DCPNS Action Committee Dr. Lynne Harrigan Brenda Cook Peggy Dunbar Bev Harpell with the assistance

More information

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention

More information

CVD Prevention, Who to Consider

CVD Prevention, Who to Consider Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..

More information

Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients. Copyright. Not for Sale or Commercial Distribution

Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients. Copyright. Not for Sale or Commercial Distribution CLINICAL Viewpoint Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients Copyright Not for Sale or Commercial Distribution By Ruth McPherson, MD, PhD, FRCPC Unauthorised

More information

Identification of subjects at high risk for cardiovascular disease

Identification of subjects at high risk for cardiovascular disease Master Class in Preventive Cardiology Focus on Diabetes and Cardiovascular Disease Geneva April 14 2011 Identification of subjects at high risk for cardiovascular disease Lars Rydén Karolinska Institutet

More information

Effects of Statins on Endothelial Function in Patients with Coronary Artery Disease

Effects of Statins on Endothelial Function in Patients with Coronary Artery Disease Effects of Statins on Endothelial Function in Patients with Coronary Artery Disease Iana I. Simova, MD; Stefan V. Denchev, PhD; Simeon I. Dimitrov, PhD Clinic of Cardiology, University Hospital Alexandrovska,

More information

Prevalence study of hypertension among adults in an urban area of Jammu

Prevalence study of hypertension among adults in an urban area of Jammu 2014; 3 (2): 143-147 Available online at: www.jsirjournal.com Research Article ISSN 2320-4818 JSIR 2014; 3(2): 143-147 2014, All rights reserved Received: 01-03-2014 Accepted: 30-04-2014 Dr. Renu Rani

More information

Study of serum Lipid Profile patterns of Indian population in young Ischaemic Heart Disease

Study of serum Lipid Profile patterns of Indian population in young Ischaemic Heart Disease Original article: Study of serum Lipid Profile patterns of Indian population in young Ischaemic Heart Disease Dr Sonu Yadav, Dr Abhijit Nikam, Dr Vivek Chiddarwar, Dr A L Kakrani Department of Medicine,

More information

Echocardiography analysis in renal transplant recipients

Echocardiography analysis in renal transplant recipients Original Research Article Echocardiography analysis in renal transplant recipients S.A.K. Noor Mohamed 1*, Edwin Fernando 2, 1 Assistant Professor, 2 Professor Department of Nephrology, Govt. Stanley Medical

More information

A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus

A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus Original Research Article A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus Deepa Kalikavil Puthenveedu 1, Sundaraj

More information

Dyslipidemia in the light of Current Guidelines - Do we change our Practice?

Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dato Dr. David Chew Soon Ping Senior Consultant Cardiologist Institut Jantung Negara Atherosclerotic Cardiovascular Disease

More information

Clinical Recommendations: Patients with Periodontitis

Clinical Recommendations: Patients with Periodontitis The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease. Friedewald VE, Kornman KS, Beck JD, et al. J Periodontol 2009;

More information

Update on Dyslipidemia and Recent Data on Treating the Statin Intolerant Patient

Update on Dyslipidemia and Recent Data on Treating the Statin Intolerant Patient Update on Dyslipidemia and Recent Data on Treating the Statin Intolerant Patient Steven E. Nissen MD Chairman, Department of Cardiovascular Medicine Cleveland Clinic Disclosure Consulting: Many pharmaceutical

More information

ATP IV: Predicting Guideline Updates

ATP IV: Predicting Guideline Updates Disclosures ATP IV: Predicting Guideline Updates Daniel M. Riche, Pharm.D., BCPS, CDE Speaker s Bureau Merck Janssen Boehringer-Ingelheim Learning Objectives Describe at least two evidence-based recommendations

More information

ISSN: X Impact factor: 4.295

ISSN: X Impact factor: 4.295 ISSN: 2454-132X Impact factor: 4.295 (Volume3, Issue1) Available online at: www.ijariit.com A Cross Sectional Study for Evaluation of Association between Hypertensive Retinopathy with Serum Lipid Profile

More information

Prevalence and risk factors of hypertension, among adults residing in an urban area of North India

Prevalence and risk factors of hypertension, among adults residing in an urban area of North India Available online at www.ijpab.com INTERNATIONAL JOURNAL OF PURE & APPLIED BIOSCIENCE ISSN: 2320 7051 Int. J. Pure App. Biosci. 3 (2): 338-344 (2015) Research Article Prevalence and risk factors of hypertension,

More information

Clinical presentation, gender and age profile of acute coronary syndrome - multicentre observational analysis in Vijayapur in North Karnataka

Clinical presentation, gender and age profile of acute coronary syndrome - multicentre observational analysis in Vijayapur in North Karnataka Original article Clinical presentation, gender and age profile of acute coronary syndrome - multicentre observational analysis in Vijayapur in North Karnataka Satish Talikoti 1, Nijora Deka 2 1Assistant

More information

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD

More information

Original Articles. Socioeconomic status and dyslipidaemia in a South Indian population: The Chennai Urban Population Study (CUPS 11)

Original Articles. Socioeconomic status and dyslipidaemia in a South Indian population: The Chennai Urban Population Study (CUPS 11) 64 MISHRA et al. : BYSSINOSIS AMONG MALE TEXTILE WORKERS THE NATIONAL MEDICAL JOURNAL OF INDIA VOL. 16, NO. 2, 2003 Original Articles Socioeconomic status and dyslipidaemia in a South Indian population:

More information

Journal of the American College of Cardiology Vol. 38, No. 3, by the American College of Cardiology ISSN /01/$20.

Journal of the American College of Cardiology Vol. 38, No. 3, by the American College of Cardiology ISSN /01/$20. Journal of the American College of Cardiology Vol. 38, No. 3, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01415-2 Prevalence

More information

Comprehensive Treatment for Dyslipidemias. Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium

Comprehensive Treatment for Dyslipidemias. Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium Comprehensive Treatment for Dyslipidemias Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium Primary Prevention 41 y/o healthy male No Medications Normal BP, Glucose and BMI Social History:

More information

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study Panel Discussion: Literature that Should Have an Impact on our Practice: The Study Kaiser COAST 11 th Annual Conference Maui, August 2009 Robert Blumberg, MD, FACC Ralph Brindis, MD, MPH, FACC Primary

More information

On May 2001, the Third Adult

On May 2001, the Third Adult THE RISK OF DIABETES: CAN WE IMPACT CHD THROUGH THE ATP III CHOLESTEROL GUIDELINES? * Based on a presentation given by Steven M. Haffner, MD, MPH ABSTRACT Diabetes has been recognized among diabetologists

More information

The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009

The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009 The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009 Learning Objectives 1. Understand the role of statin therapy in the primary and secondary prevention of stroke 2. Explain

More information

PIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia

PIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia PIEDMONT ACCESS TO HEALTH SERVICES, INC. Policy Number: 01-09-021 SUBJECT: Guidelines for Screening and Management of Dyslipidemia EFFECTIVE DATE: 04/2008 REVIEWED/REVISED: 04/12/10, 03/17/2011, 4/10/2012,

More information

Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients

Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients ORIGINAL ARTICLES Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients Andrew C. Novick, MD, Safwat Zald, MD, David Goldfarb, MD, and Ernest E. Hodge, MD,

More information

High Density Lipoprotein Cholesterol and Mortality

High Density Lipoprotein Cholesterol and Mortality High Density Lipoprotein Cholesterol and Mortality The Framingham Heart Study Peter W.F. Wilson, Robert D. Abbott, and William P. Castelli In 12 years of follow-up for 2748 Framingham Heart Study participants

More information

Coronary artery disease epidemic in Pakistan: more electrocardiographic evidence of ischaemia in women than in men

Coronary artery disease epidemic in Pakistan: more electrocardiographic evidence of ischaemia in women than in men 1 Clinical Epidemiology Unit, Department of Community Health Sciences, Aga Khan University, Karachi, Pakistan; 2 International Centre for Circulatory Health, National Heart and Lung Institute, Imperial

More information

RESEARCH ARTICLE. Abbasi et al., IJAVMS, Vol. 6, Issue 5, 2012: DOI: /ijavms.24458

RESEARCH ARTICLE. Abbasi et al., IJAVMS, Vol. 6, Issue 5, 2012: DOI: /ijavms.24458 RESEARCH ARTICLE Abbasi et al., IJAVMS, Vol. 6, Issue 5, : 385-39 DOI:.5455/ijavms.4458 Prevalence and Awareness of Cardiovascular Disease Risk Factors in the Government Servants of Muzaffarabad, the Capital

More information

Pattern of plasma lipoprotein (a) in Sudanese patients with coronary

Pattern of plasma lipoprotein (a) in Sudanese patients with coronary Pattern of plasma lipoprotein (a) in Sudanese patients with coronary artery disease Mansour Eltahir Farah 1, Khairia Eltahir Abdullah 2, Huda HM Elhassan 3, Mohammed O EH Gadour 1, Mohammed Saeed Alkhaleefa

More information

Life Science Journal 2018;15(12)

Life Science Journal 2018;15(12) Multicenter observational study of risk factors profile in a sample of Egyptian Patients with Acute Coronary Syndrome (part of Egyptian Cardiovascular Risk Factors Project) Prof. Dr. Ahmed Ashraf Reda,

More information

Metabolic Syndrome: Why Should We Look For It?

Metabolic Syndrome: Why Should We Look For It? 021-CardioCase 29/05/06 15:04 Page 21 Metabolic Syndrome: Why Should We Look For It? Dafna Rippel, MD, MHA and Andrew Ignaszewski, MD, FRCPC CardioCase presentation Andy s fatigue Andy, 47, comes to you

More information

FREQUENCY OF CONVENTIONAL RISK FACTORS AMONG CORONORY ARTERY DISEASE PATIENTS IN TRIBAL AREA OF PAKISTAN

FREQUENCY OF CONVENTIONAL RISK FACTORS AMONG CORONORY ARTERY DISEASE PATIENTS IN TRIBAL AREA OF PAKISTAN ORIGINAL ARTICLE Pak Heart J FREQUENCY OF CONVENTIONAL RISK FACTORS AMONG CORONORY ARTERY DISEASE PATIENTS IN TRIBAL AREA OF PAKISTAN 1 3 4 Muhammad Asif Iqbal, Ikramullah, Abdul Hadi, Muhammad Farooq,

More information

Cardiovascular Complications of Diabetes

Cardiovascular Complications of Diabetes VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary

More information

Risk Factors for Ischemic Stroke: Electrocardiographic Findings

Risk Factors for Ischemic Stroke: Electrocardiographic Findings Original Articles 232 Risk Factors for Ischemic Stroke: Electrocardiographic Findings Elley H.H. Chiu 1,2, Teng-Yeow Tan 1,3, Ku-Chou Chang 1,3, and Chia-Wei Liou 1,3 Abstract- Background: Standard 12-lead

More information

DISTRIBUTION AND DETERMINANTS OF CORONARY ARTERY DISEASE

DISTRIBUTION AND DETERMINANTS OF CORONARY ARTERY DISEASE DISTRIBUTION AND DETERMINANTS OF CORONARY ARTERY DISEASE IN AN URBAN PAKISTANI SETTING Objective: We assessed the distribution of coronary artery disease (CAD) and its association with the major biological

More information

LIPIDS AND CHOLESTEROL - RISK FACTORS TO A POLICE UNIT FROM BRASOV

LIPIDS AND CHOLESTEROL - RISK FACTORS TO A POLICE UNIT FROM BRASOV Bulletin of the Transilvania University of Braşov Series VI: Medical Sciences Vol. 4 (53) No. 2-2011 LIPIDS AND CHOLESTEROL - RISK FACTORS TO A POLICE UNIT FROM BRASOV C. DOBRESCU 1 I. MOLEAVIN 1 Abstract:

More information

CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES

CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES C. Liakos, 1 G. Vyssoulis, 1 E. Karpanou, 2 S-M. Kyvelou, 1 V. Tzamou, 1 A. Michaelides, 1 A. Triantafyllou, 1 P. Spanos, 1 C. Stefanadis

More information

HIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES

HIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES HIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES A study published in the British Medical Journal shows that not only is high LDL cholesterol not a risk factor for all-caused

More information

Differential impact of aging and gender on lipid and lipoprotein profiles in a cohort of healthy Chinese Singaporeans

Differential impact of aging and gender on lipid and lipoprotein profiles in a cohort of healthy Chinese Singaporeans Asian J Androl 2007; 9 (6): 787 794 DOI: 10.1111/j.1745-7262.2007.00294.x www.asiaandro.com. Original Article. Differential impact of aging and gender on lipid and lipoprotein profiles in a cohort of healthy

More information

Prevalence of Ischemic Heart Disease Among Urban Population of Siliguri, West Bengal

Prevalence of Ischemic Heart Disease Among Urban Population of Siliguri, West Bengal Original Article Prevalence of Ischemic Heart Disease Among Urban Population of Siliguri, West Bengal Sukanta Mandal, Joyti Bikash Saha, Sankar Chandra Mandal 1, Rudra Nath Bhattacharya, Manashi Chakraborty,

More information

PATTERN OF ANGIOGRAPHIC FINDINGS IN YOUNG PATIENTS PRESENTING WITH ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION

PATTERN OF ANGIOGRAPHIC FINDINGS IN YOUNG PATIENTS PRESENTING WITH ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION Pak Heart J ORIGINAL ARTICLE PATTERN OF ANGIOGRAPHIC FINDINGS IN YOUNG PATIENTS PRESENTING WITH ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION Burhan Akhtar, Nauman Ali, Rana Kashif - Department Of Cardiology,

More information

the U.S. population, have some form of cardiovascular disease. Each year, approximately 6 million hospitalizations

the U.S. population, have some form of cardiovascular disease. Each year, approximately 6 million hospitalizations Cardioprotection: What is it? Who needs it? William B. Kannel, MD, MPH From the Department of Preventive Medicine and Epidemiology, Evans Department of Clinical Research, Boston University School of Medicine,

More information

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups A: Epidemiology update Evidence that LDL-C and CRP identify different high-risk groups Women (n = 27,939; mean age 54.7 years) who were free of symptomatic cardiovascular (CV) disease at baseline were

More information

LIST OF ABBREVIATIONS

LIST OF ABBREVIATIONS Diabetes & Endocrinology 2005 Royal College of Physicians of Edinburgh Diabetes and lipids 1 G Marshall, 2 M Fisher 1 Research Fellow, Department of Cardiology, Glasgow Royal Infirmary, Glasgow, Scotland,

More information

CVD Risk Assessment. Lipid Management in Women: Lessons Learned. Conflict of Interest Disclosure

CVD Risk Assessment. Lipid Management in Women: Lessons Learned. Conflict of Interest Disclosure Lipid Management in Women: Lessons Learned Conflict of Interest Disclosure Emma A. Meagher, MD has no conflicts to disclose Emma A. Meagher, MD Associate Professor, Medicine and Pharmacology University

More information

CVD risk assessment using risk scores in primary and secondary prevention

CVD risk assessment using risk scores in primary and secondary prevention CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities

More information

New Features of the National Cholesterol Education Program Adult Treatment Panel III Lipid-Lowering Guidelines

New Features of the National Cholesterol Education Program Adult Treatment Panel III Lipid-Lowering Guidelines Clin. Cardiol. Vol. 26 (Suppl. III), III-19 III-24 (2003) New Features of the National Cholesterol Education Program Adult Treatment Panel III Lipid-Lowering Guidelines H. BRYAN BREWER, JR, M.D. Molecular

More information

HYPERLIPIDEMIA IN THE OLDER POPULATION NICOLE SLATER, PHARMD, BCACP AUBURN UNIVERSITY, HARRISON SCHOOL OF PHARMACY JULY 16, 2016

HYPERLIPIDEMIA IN THE OLDER POPULATION NICOLE SLATER, PHARMD, BCACP AUBURN UNIVERSITY, HARRISON SCHOOL OF PHARMACY JULY 16, 2016 HYPERLIPIDEMIA IN THE OLDER POPULATION NICOLE SLATER, PHARMD, BCACP AUBURN UNIVERSITY, HARRISON SCHOOL OF PHARMACY JULY 16, 2016 NOTHING TO DISCLOSE I, Nicole Slater, have no actual or potential conflict

More information

Current Cholesterol Guidelines and Treatment of Residual Risk COPYRIGHT. J. Peter Oettgen, MD

Current Cholesterol Guidelines and Treatment of Residual Risk COPYRIGHT. J. Peter Oettgen, MD Current Cholesterol Guidelines and Treatment of Residual Risk J. Peter Oettgen, MD Associate Professor of Medicine Harvard Medical School Director, Preventive Cardiology Beth Israel Deaconess Medical Center

More information

Is Universal Pediatric Lipid Screening Justified? YES. Damon Dixon, MD, FAAP Preventative Cardiology March 7 th, 2016

Is Universal Pediatric Lipid Screening Justified? YES. Damon Dixon, MD, FAAP Preventative Cardiology March 7 th, 2016 Is Universal Pediatric Lipid Screening Justified? YES Damon Dixon, MD, FAAP Preventative Cardiology March 7 th, 2016 None Disclosures What is a Pediatrician? Pediatrics is the specialty of medical science

More information

MOLINA HEALTHCARE OF CALIFORNIA

MOLINA HEALTHCARE OF CALIFORNIA MOLINA HEALTHCARE OF CALIFORNIA HIGH BLOOD CHOLESTEROL IN ADULTS GUIDELINE Molina Healthcare of California has adopted the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel

More information

STATIN UTILIZATION MANAGEMENT CRITERIA

STATIN UTILIZATION MANAGEMENT CRITERIA STATIN UTILIZATION MANAGEMENT CRITERIA DRUG CLASS: HMG Co-A Reductase Inhibitors & Combinations Agents which require prior review: Advicor (niacin extended-release/lovastatin) Crestor (rosuvastatin)(5mg,10mg,

More information

Original Article. Study of Lipid Profile in Postmenopausal Rural Women and Its Correlation with Carotid Intima Media Thickness Chaoji S A, Humne N

Original Article. Study of Lipid Profile in Postmenopausal Rural Women and Its Correlation with Carotid Intima Media Thickness Chaoji S A, Humne N Original Article Vidarbha Journal of Internal Medicine Volume 19 July 2015 Study of Lipid Profile in Postmenopausal Rural Women and Its Correlation with Carotid Intima Media Thickness 1 2 Chaoji S A, Humne

More information

Acute Coronary Syndromes (ACS)

Acute Coronary Syndromes (ACS) Sally A. Arif, Pharm.D., BCPS (AQ Cardiology) Assistant Professor of Pharmacy Practice Midwestern University, Chicago College of Pharmacy Cardiology Clinical Specialist, Rush University Medical Center

More information

EXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT Submitted to UNIVERSITY GRANTS COMMISSION

EXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT Submitted to UNIVERSITY GRANTS COMMISSION 1 A STUDY ON THE EFFECT OF DIET & LIFE STYLE ON THE INCIDENCE OF CORONARY ARTERY DISEASE IN MODERATELY DRINKING EX MILITARY MEN IN PATHANAMTHITTA DISTRICT. EXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT

More information

Established Risk Factors for Coronary Heart Disease (CHD)

Established Risk Factors for Coronary Heart Disease (CHD) Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland

More information

Dyslipidemia in women: Who should be treated and how?

Dyslipidemia in women: Who should be treated and how? Dyslipidemia in women: Who should be treated and how? Lale Tokgozoglu, MD, FACC, FESC Professor of Cardiology Hacettepe University Faculty of Medicine Ankara, Turkey. Cause of Death in Women: European

More information

Original Article. Gautam A.G 1, Bansal P 2, Chauhan R 3, Chadha V 4 NTRODUCTION

Original Article. Gautam A.G 1, Bansal P 2, Chauhan R 3, Chadha V 4 NTRODUCTION Original Article A Prospective Study To Know Socio-Demographic Profile In Patients With Acute Coronary Syndrome Admitted At A Tertiary Health Care And Teaching Hospital In Himachal Pradesh, North India

More information

The presence of cardiovascular disease risk factors, clinical

The presence of cardiovascular disease risk factors, clinical The Impact of JNC-VI Guidelines on Treatment Recommendations in the US Population Paul Muntner, Jiang He, Edward J. Roccella, Paul K. Whelton Abstract Using epidemiological and clinical trial evidence,

More information

Original article : Correlation of Lipid level in Thyroid Disorder Patients: A Case Control Study

Original article : Correlation of Lipid level in Thyroid Disorder Patients: A Case Control Study Original article : Correlation of Lipid level in Thyroid Disorder Patients: A Case Control Study Dr. Arohi Kumar Associate Professor, Department of General Medicine, Narayan Medical College & Hospital,

More information

Lipoprotein Particle Profile

Lipoprotein Particle Profile Lipoprotein Particle Profile 50% of people at risk for HEART DISEASE are not identified by routine testing. Why is LPP Testing The Most Comprehensive Risk Assessment? u Provides much more accurate cardiovascular

More information

Latest Guidelines for Lipid Management

Latest Guidelines for Lipid Management Latest Guidelines for Lipid Management Goals Recognize the differences between different guidelines Understand the effective strategies to tailor lipid lowering therapies based on evidence and guideline

More information